Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.

Siegman-Igra Y, Reich P, Orni-Wasserlauf R, Schwartz D, Giladi M.

Scand J Infect Dis. 2005;37(8):572-578.

PMID:
16138425
2.

Diagnosis and management of Staphylococcus aureus bacteraemia.

Mitchell DH, Howden BP.

Intern Med J. 2005 Dec;35 Suppl 2:S17-24. Review.

PMID:
16271058
3.

Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.

Khatib R, Johnson LB, Sharma M, Fakih MG, Ganga R, Riederer K.

Scand J Infect Dis. 2009;41(1):4-9. doi: 10.1080/00365540802441711.

PMID:
18821135
4.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):333-9.

5.

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.

Shorr AF, Kunkel MJ, Kollef M.

J Antimicrob Chemother. 2005 Nov;56(5):923-9. Epub 2005 Sep 29.

PMID:
16195255
6.

Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.

Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U.

Clin Microbiol Infect. 2006 Apr;12(4):345-52.

7.

Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.

Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, Campion M, Abrutyn E, Levine DP, Price CS, Rehm SJ, Corey GR, Karchmer AW; S. aureus Endocarditis and Bacteraemia Study Group.

J Antimicrob Chemother. 2008 Jan;61(1):177-82. Epub 2007 Nov 13.

PMID:
17999973
8.

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2008 Jan;52(1):192-7. Epub 2007 Nov 5.

9.

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.

Goldberg E, Paul M, Talker O, Samra Z, Raskin M, Hazzan R, Leibovici L, Bishara J.

J Antimicrob Chemother. 2010 Aug;65(8):1779-83. doi: 10.1093/jac/dkq179. Epub 2010 May 27.

PMID:
20507860
10.

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW.

Clin Infect Dis. 2003 Sep 15;37(6):794-9. Epub 2003 Aug 23.

PMID:
12955640
11.

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.

Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A.

Ann Intern Med. 1996 Dec 15;125(12):969-74.

PMID:
8967707
12.
13.

CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Tong SY, Nelson J, Paterson DL, Fowler VG Jr, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O'Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS; CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network.

Trials. 2016 Mar 31;17:170. doi: 10.1186/s13063-016-1295-3.

14.

Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.

Ruotsalainen E, Kardén-Lilja M, Kuusela P, Vuopio-Varkila J, Virolainen-Julkunen A, Sarna S, Valtonen V, Järvinen A.

J Infect. 2008 Apr;56(4):249-56. doi: 10.1016/j.jinf.2008.01.009. Epub 2008 Mar 7.

PMID:
18314197
15.

Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.

Kim SH, Park WB, Lee CS, Kang CI, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.

Clin Microbiol Infect. 2006 Jan;12(1):13-21.

16.

Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.

Lesse AJ, Mylotte JM.

Am J Infect Control. 2006 Dec;34(10):642-50.

PMID:
17161739
17.

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.

Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N.

J Antimicrob Chemother. 1988 Jan;21 Suppl A:81-7.

PMID:
2965135
18.

Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.

Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, White AC Jr.

J Infect. 2007 Jun;54(6):539-44. Epub 2007 Jan 2.

PMID:
17198732
19.

[Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].

Espinosa FJ, Valdés M, Martín-Luengo F, Arribas JP, Albaladejo J, Pérez-Gracia A, García-Henarejos JA, Martínez-Madrid O, García-Alberola A.

Enferm Infecc Microbiol Clin. 1993 May;11(5):235-40. Spanish.

PMID:
8324018
20.

[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].

Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.

Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33. Czech.

PMID:
17140514

Supplemental Content

Support Center